Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 August 2022 | Story Andre Damons | Photo Supplied
Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology, will jet off to Lomé, Togo, later this month, where he will share his knowledge and expertise on the production of herbal medicines at a special event of the World Health Organisation (WHO) Health Ministers Regional Committee for Africa.

Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology, will share his knowledge and expertise on the production of herbal medicines at a special event of the World Health Organisation (WHO) Health Ministers Regional Committee for Africa taking place in Lomé, Togo.

This meeting, with the theme Building Back Better: Rethinking and rebuilding resilient health systems in Africa to achieve UHC and health security, is the 72nd session of the WHO Regional Committee for Africa and will take place between 22 and 26 August 2022. The session will be attended by African health ministers as well as the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, WHO Afro Regional Director, Dr Matshidiso Moeti, and our own Minister of Health, Dr Joe Phaahla, among the key attendees.

Prof Matsabisa will give a presentation on fast-tracking research and development and local production of herbal medicines during the second session, with the theme: Lessons to guide strengthening of health product manufacturing in Africa. He will address the meeting as Chairperson of the Regional Advisory Committee on Traditional Medicine for COVID-19 response (REACT).

Event will launch a consultative process of learning

According to documents about the event, the purpose of the meeting is for the WHO Africa Regional Office (AFRO) to seek to collectively develop a roadmap for building resilient health systems. This comes through integrated efforts that coordinated actions across all clusters and teams in the WHO’s regional and country offices, as well as with national, regional, and global partners supporting African countries as they ramp up efforts to recover from the pandemic-induced disruption and build back better towards achieving universal health coverage (UHC) and being prepared for future health emergencies.

This event will launch a consultative process to learn from the lessons and experiences of countries and partners regarding the implementation and identifying successful health system strategies, and to obtain insights from leaders in the region to guide the next steps. The outcomes of the discussions will be used to inform an urgent common approach to building resilient health systems to achieve health security and UHC in Africa.

Prof Matsabisa says he is delighted to be given the opportunity as Chair of REACT to influence the ministers of health on the continent, as well as other key influential persons, to look favourably at inward investing in the development of local therapeutics, including those from natural products. This would not only address health, but broadly cover local industrial development of the herbal industry, job creation, and wealth generation based on our natural resources.  
“I believe it is time that we move away from thinking of procuring products and services and also looking for aid, but to wake up and stand up to do things for ourselves. Vaccine nationalisations have taught us a bitter lesson that we don’t want to repeat.”  

“I wish to relay that the WHO missions I undertook to the many African countries to determine the capabilities for product manufacturing, clinical trials, and research and development, have indicated that Africa has the manpower, the science, technologies, as well as infrastructure capabilities for the local manufacturing of pharmaceutical therapeutics,” says Prof Matsabisa. 

His presentation will be about the readiness of Africa to develop therapeutics for priority diseases based on herbal-based natural products, as well as our readiness – as the continent – to act should we be faced with another pandemic.

COVID-19 did well to prepare the continent for the next major health emergency

Prof Matsabisa will be one of the six panellists for this ministerial session (Session 2: Lessons to guide strengthening of health-product manufacturing in Africa), moderated by Ms Redi Tlhabi. The other panellists will be Hon. Prof Abderrahmane Benbouzid, Minister of Health, Population and Hospital Reform in Algeria; Hon. Dr Joe Phaahla, Minister of Health, South Africa; Dr Ngozi Okonjo-Iweala, Director General, World Trade Organisation; HE Amb. Minata Samate, Commissioner for Health, Humanitarian Affairs and Social Development, AU; and Mr Emmanuel Mujuru, Chair, Federation of African Pharmaceutical Manufacturers Associations. The session will also be attended by the WHO Director, Dr Ghebreyesus, the WHO Afro Regional Director, Dr Moeti, as well as the presidents and ministers of Togo and Senegal.

Prof Matsabisa says COVID-19 did well to prepare the continent for the next major health emergency, and Africa would now be better suited to deal with such. The meeting in Lomé will share those lessons, which ones worked, why they worked, and learn from those that did not work.  

“We cannot, again, be caught off guard and found wanting and be at the mercy of the North for donations and continue to talk about procurement. I will present ways to put in place systems to support the local manufacturing of therapeutics with participation through the African regional economic blocks.” 

“I will also ask the ministers to help with three things: first, to ask the ministers and their heads of state and governments to financially support the R&D and local manufacturing of herbal-based therapeutics, as well as support for the clinical research of African traditional medicines. Second, to support the WHO and its partners in the mobilisation of resources for traditional medicines against COVID-19, as well as for other priority diseases. Third will be to inform the ministers that REACT is ready to be the coordinator for the R&D and support for the clinical trials at country level, and to develop a coordinated collaborative approach to the R&D and local manufacturing, including clinical trials.”

News Archive

Heart diseases a time bomb in Africa, says UFS expert
2010-05-17

 Prof. Francis Smit

There are a lot of cardiac problems in Africa. Sub-Saharan Africa is home to the largest population of rheumatic heart disease patients in the world and therefore hosts the largest rheumatic heart valve population in the world. They are more than one million, compared to 33 000 in the whole of the industrialised world, says Prof. Francis Smit, Head of the Department of Cardiothoracic Surgery at the Faculty of Health Sciences at the University of the Free State (UFS).

He delivered an inaugural lecture on the topic Cardiothoracic Surgery: Complex simplicity, or simple complexity?

“We are also sitting on a time bomb of ischemic heart disease with the WHO (World Health Organisation) estimating that CAD (coronary artery disease) will become the number-one killer in our region by 2020. HIV/Aids is expected to go down to number 7.”

Very little is done about it. There is neither a clear nor coordinated programme to address this expected epidemic and CAD is regarded as an expensive disease, confined to Caucasians in the industrialised world. “We are ignoring alarming statistics about incidences of adult obesity, diabetes and endemic hypertension in our black population and a rising incidence of coronary artery interventions and incidents in our indigenous population,” Prof. Smit says.

Outside South Africa – with 44 units – very few units (about seven) perform low volumes of basic cardiac surgery. The South African units at all academic institutions are under severe threat and about 70% of cardiac procedures are performed in the private sector.

He says the main challenge in Africa has become sustainability, which needs to be addressed through education. Cardiothoracic surgery must become part of everyday surgery in Africa through alternative education programmes. That will make this specialty relevant at all levels of healthcare and it must be involved in resource allocation to medicine in general and cardiothoracic surgery specifically.

The African surgeon should make the maximum impact at the lowest possible cost to as many people in a society as possible. “Our training in fields like intensive care and insight into pulmonology, gastroenterology and cardiology give us the possibility of expanding our roles in African medicine. We must also remember that we are trained physicians as well.

“Should people die or suffer tremendously while we can train a group of surgical specialists or retraining general surgeons to expand our impact on cardiothoracic disease in Africa using available technology maybe more creatively? We have made great progress in establishing an African School for Cardiothoracic Surgery.”

Prof. Smit also highlighted the role of the annual Hannes Meyer National Registrar Symposium that culminated in having an eight-strong international panel sponsored by the ICC of EACTS to present a scientific course as well as advanced surgical techniques in conjunction with the Hannes Meyer Symposium in 2010.

Prof. Smit says South Africa is fast becoming the driving force in cardiothoracic surgery in Africa. South Africa is the only country that has the knowledge, technology and skills base to act as the springboard for the development of cardiothoracic surgery in Africa.

South Africa, however, is experiencing its own problems. Mortality has doubled in the years from 1997 to 2005 and half the population in the Free State dies between 40 to 44 years of age.

“If we do not need health professionals to determine the quality and quantity of service delivery to the population and do not want to involve them in this process, we can get rid of them, but then the political leaders making that decision must accept responsibility for the clinical outcomes and life expectancies of their fellow citizens.

“We surely cannot expect to impose the same medical legal principles on professionals working in unsafe hospitals and who have complained and made authorities aware of these conditions than upon those working in functional institutions. Either fixes the institutions or indemnifies medical personnel working in these conditions and defends the decision publicly.

“Why do I have to choose the three out of four patients that cannot have a lifesaving operation and will have to die on their own while the system pretends to deliver treatment to all?”

Prof. Smit says developing a service package with guidelines in the public domain will go a long way towards addressing this issue. It is also about time that we have to admit that things are simply not the same. Standards are deteriorating and training outcomes are or will be affected.

The people who make decisions that affect healthcare service delivery and outcomes, the quality of training platforms and research, in a word, the future of South African medicine, firstly need rules and boundaries. He also suggested that maybe the government should develop health policy in the public domain and then outsource healthcare delivery to people who can actually deliver including thousands of experts employed but ignored by the State at present.

“It is time that we all have to accept our responsibilities at all levels… and act decisively on matters that will determine the quality and quantity of medical care for this and future generations in South Africa and Africa. Time is running out,” Prof. Smit says.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept